Friday, September 21, 2018 2:55:28 PM
GOOD NEWS:
IT'S FRIDAY
BAD NEWS:
I misread the IMS report two weeks ago and it's not as bright as I reported. My Apologies. While the TRX numbers suck they should improve as the NRX numbers mature.
Current Report Of Copaxone TRX Sales:
Teva 40MG 66%
TEVA 20MG 11%
MYLAN 40MG 15% (1746)
MYLAN 20MG 1%
SANDOZ 40MG 2%
SANDOZ 20MG 4% (513)
CURRENT REPORT OF COPAXONE NRX SALES:
TEVA 40MG 38%
TEVA 20MG 8%
MYLAN 40MG 29%
MYLAN 20MG 6%
SANDOZ 40MG 12%
SANDOZ 20MG 7%
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM